India’s TB Control Gains Continue, but Elimination Target Remains Elusive

Context:

  • The WHO Global Tuberculosis Report 2025 highlights that while India has achieved a significant decline in TB incidence, it continues to shoulder the largest global TB burden.

  • Despite early adoption of ambitious goals, India missed its 2025 TB elimination target, underscoring persistent structural and public health challenges.

Key Highlights:

Disease Burden and Trends

  • TB incidence in India declined by 21% between 2015 and 2024, indicating sustained progress.

  • India accounts for 25% of the global TB burden, the highest worldwide.

  • TB mortality rate reduced from 28 to 21 deaths per lakh population during the same period.

  • However, the elimination target for 2025 remains unmet, despite being set five years ahead of the global 2030 goal.

Regional Distribution

  • Uttar Pradesh reports the highest absolute number of TB cases, followed by:

    • Maharashtra

    • Bihar

    • Madhya Pradesh

  • Delhi records the highest TB prevalence rate, despite not having the highest case count.

Drug-Resistant TB Challenge

  • India contributed 32% of global MDR-TB and rifampicin-resistant TB cases in 2024.

  • Treatment success rate:

    • 90% for drug-sensitive TB cases.

    • Only 77% for MDR-/RR-TB, indicating a major treatment gap.

Government Initiative / Programme Details

  • Implemented under the National TB Elimination Programme (NTEP).

  • Focus areas include:

    • Early diagnosis

    • Universal drug susceptibility testing

    • Free treatment and nutritional support

  • Introduction of newer treatment regimens, including BPaLM therapy for drug-resistant TB.

Technological and Policy Interventions

  • Use of molecular diagnostics and AI-based screening tools to improve early detection.

  • Emphasis on:

    • Improved nutrition support

    • Adoption of shorter, more effective drug regimens

  • Yet, gaps persist in:

    • Timely diagnosis

    • Drug availability

    • Addressing malnutrition and socio-economic determinants

Concerns and Gaps

  • High MDR-/RR-TB burden threatens overall TB control gains.

  • Socioeconomic disparities, urban overcrowding, and undernutrition continue to fuel transmission.

  • India’s current TB mortality rate remains over three times higher than the elimination benchmark.

  • Risk of complacency despite measurable progress.

UPSC Relevance (GS-wise):

GS 2 – Social Justice

  • Public health as a component of social justice

  • Impact of TB on vulnerable and economically weaker sections

  • Access to healthcare and nutritional support

GS 2 – Governance

  • Performance and challenges of national health programmes

  • Centre–State coordination in disease control

  • Health policy implementation and monitoring

GS 3 – Science & Technology

  • Role of diagnostic technologies and new drug regimens

  • Application of AI in healthcare

  • Innovation in treatment of infectious diseases

Prelims Focus:

  • WHO Global TB Report

  • MDR-TB and RR-TB

  • National TB Elimination Programme

  • TB elimination targets (India vs global)

Mains Orientation:

  • Analyse why India missed its 2025 TB elimination target despite significant gains.

  • Discuss the role of technology, nutrition, and governance reforms in accelerating TB elimination.

« Prev March 2026 Next »
SunMonTueWedThuFriSat
1234567
891011121314
15161718192021
22232425262728
293031